Grifols
XEMBIFY
Manufacturer:
Grifols
Name:
XEMBIFY
HCPCS Code Descriptor:
Injection, immune globulin (xembify), 100 mg
Category:
J Code
HCPCS:
J1558
NDC(s):
13533-0810-05, 13533-0810-10, 13533-0810-20, 13533-0810-50
Primary Type:
Immunoglobulin
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
XEMBIFY is an Immunoglobulin drug manufactured by Grifols and administered via the Subcutaneous route of administration. The J Code: J1558 is aligned to the drug XEMBIFY.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/20
HCPCS Effective Date:
7/1/20
HCPCS Short Description:
Inj. xembify, 100 mg
Billing and Coding Guide:
https://www.xembify.com/documents/2600280/2601534/XEMBIFY-Reimbursement-Guide-2020.pdf/84838316-ce22-4a16-bd5f-f6d5eeddf274?t=1607083046677
Patient Assistance:
https://www.xembify.com/en/patients/xembify-connexions